Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Guanidines Stories

2013-07-16 12:27:54

TAIPEI, July 16, 2013 /PRNewswire/ -- TWi Pharmaceuticals, Inc., today announced that it has received an official notification of patent allowance for its metformin controlled release formulation from United States Patent & Trademark Office. The granted patent, US patent number 8,486,453, claims cover the controlled-release composition of TWi's metformin product with reduced food effect. The patent is part of TWi Pharmaceuticals' broad intellectual property portfolio for building...

2013-07-10 16:26:00

HOUSTON, July 10, 2013 /PRNewswire-USNewswire/ -- Drugs that help millions of people cope with acid reflux may also cause cardiovascular disease, report scientists from Houston Methodist Hospital and two other institutions in an upcoming issue of Circulation (now online). It is the first time researchers have shown how proton pump inhibitors, or PPIs, might cause cardiovascular problems. In human tissue and mouse models, the researchers found PPIs caused the constriction of blood...

2013-07-09 23:00:50

The cardio health supplement, L-arginine Plus, will now be available for purchase from King Supplements. (PRWEB) July 09, 2013 King Supplements will now be offering L-arginine Plus as part of their performance, endurance, and whole body health supplements. Among these lines, King Supplements offers products designed for weight loss, pain management, and beauty. They carry not only the most popular products on the market today, but also the most proven. L-arginine Plus is a supplement...

2013-06-24 23:03:09

Research report “L-arginine Market Research in China” worked out by Guangzhou CCM Information Science & Technology Co. (CCM) has been recently published by Market Publishers Ltd. London, UK (PRWEB) June 24, 2013 In 2009-2012, the Chinese L-arginine industry registered robust growth. In 2012, many new L-arginine production lines were launched. A great number of China’s production lines have adopted fermentation method due to the development and enhancing popularity of it,...

2013-06-22 12:20:35

Data presented at the American Diabetes Association 73rd Scientific Sessions® also show statistically significant reductions in mean daily glucose and body weight in people with type 2 diabetes RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results of two phase III 24-week clinical trials of the investigational agent empagliflozin(*) added to metformin with and without...

2013-06-17 23:14:23

To view the multimedia release and for additional information, please visit http://www.takedat2dtreatments.com. (PRWEB) June 17, 2013 Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that NESINA (alogliptin) and the fixed-dose combination therapies KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) are now available by prescription in pharmacies in the United States (U.S.). These...

2013-06-17 12:28:22

DEERFIELD, Ill. and OSAKA, Japan, June 17, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that NESINA (alogliptin) and the fixed-dose combination therapies KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) are now available by prescription in pharmacies in the United States (U.S.). These medications are approved by the U.S. Food and Drug Administration (FDA)...

2013-06-14 16:25:07

SAN DIEGO, June 14, 2013 /PRNewswire/ -- Elcelyx Therapeutics today announced that the company and principal investigator Ralph A. DeFronzo, M.D. will present posters related to NewMet(TM), a delayed-release formulation of generic metformin, at the 73(rd) Scientific Sessions of the American Diabetes Association in Chicago, IL. Dr. DeFronzo, Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center and the Audie L. Murphy Memorial Veterans...

2013-06-13 04:21:45

LONDON, June 13, 2013 /PRNewswire/ -- Magicool Plus(R) range of OTC topical, Class IIa sprays were recently listed in the NHS Drug Tariff part IX, under a specially created category and is available on prescription and OTC. The range comprises Magicool Plus(R) Prickly Heat, Magicool Plus(R) Itchy Skin due to Summer Ailments and Magicool Plus(R) Sunburn, for treating mild to severe forms of the respective conditions. (Logo:...

2013-06-06 11:37:43

Manufacturer's dossier did not contain suitable data for any therapeutic indication Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy. No such...